COP
56
2
KR
34
-3
DE
46
3
PRU
57
-3
IPG
49
10
GM
65
-3
PDCO
35
-3
K
53
2
EIX
77
2
PX
75
5
MRK
22
3
MPC
47
3
AIV
68
-4
L
62
2
BMY
53
-7
EFX
32
2
HSY
34
3
EXPE
88
2
JWN
40
-2
AIG
38
-4
COP
56
2
KR
34
-3
DE
46
3
PRU
57
-3
IPG
49
10
GM
65
-3
PDCO
35
-3
K
53
2
EIX
77
2
PX
75
5
MRK
22
3
MPC
47
3
AIV
68
-4
L
62
2
BMY
53
-7
EFX
32
2
HSY
34
3
EXPE
88
2
JWN
40
-2
AIG
38
-4
Financhill
Back

iBio Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
22

IBIO
iBio

Last Price:
2.45
Seasonality Move:
-11.6%
Sell
30

NBY
NovaBay Pharmaceuticals

Last Price:
0.72
Seasonality Move:
-0.57%
Sell
22
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $2.19. The Score for IBIO is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $2.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBIO is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.71
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 37.39 Sell
Chaikin Money Flow: -44380 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.36 - 2.86) Sell
Bollinger Bands (100): (1.84 - 2.54) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 53 Buy
Chaikin Money Flow: 9133 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.48) Sell

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Sell
20-day SMA: 2.54 Sell
50-day SMA: 2.4 Sell
200-day SMA: 2.02 Buy
8-day EMA: 2.3 Sell
20-day EMA: 2.44 Sell
50-day EMA: 2.4 Sell
200-day EMA: 3.91 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.7 Buy
50-day SMA: 0.65 Buy
200-day SMA: 2.37 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Buy
50-day EMA: 0.73 Sell
200-day EMA: 5.67 Sell

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):